Study ID: BDB-AS-30039 | 2015-002510-80

Study Title

Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma

Teva Identifier

BDB-AS-30039 | 2015-002510-80

ClinicalTrials.gov Identifier

NCT02513160

Study Status

Completed

Trial Condition(s)

Persistent Asthma

Interventions

Drug: Beclomethasone Dipropionate 640 | Drug: Placebo | Drug: Beclomethasone dipropionate via 320 mcg BAI | Drug: albuterol/salbutamol | Drug: Beclomethasone dipropionate via 320 mcg MDI

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements

Gender

Female, Male

Age Range

12 Years and older

Trial Duration

September 30, 2015 - March 31, 2016

Phase

Phase 3

Study Type

Interventional